Area of research
Oncology · Immunology
Research interest
Research interests include Cancer research, STAT3, Biology, STAT protein, Signal transduction, and Cancer.
Mapping subcellular localizations of unannotated microproteins and alternative proteins with MicroID
Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening
A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma
Pooled AAV-CRISPR Screen with Targeted Amplicon Sequencing
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Ageing and the telomere connection: An intimate relationship with inflammation
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo
Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma
Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma